Progressive central cardiorespiratory rate downregulation and intensifying epilepsy lead to sudden unexpected death in epilepsy in mouse model of the most common human ATP1A3 mutation
Epilepsia · 2025
DOI: 10.1111/epi.18236 ↗Kurz gefasst
Fachartikel in der Zeitschrift Epilepsia, 2025. Verfasst von Arsen S Hunanyan und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pediatric Neurology and Developmental Medicine, Department of Pediatrics, Duke University, Durham, North Carolina, USA. Hauptthemen laut MEDLINE: Sodium-Potassium-Exchanging ATPase, Sudden Unexpected Death in Epilepsy, Mutation, Epilepsy. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, Duke University, NIGMS NIH HHS.
Abstract (Originalsprache)
Objective
This study was undertaken to test the following hypotheses in the Atp1a3 Mashl/+ mouse (which carries the most common human ATP1A3 (the major subunit of the neuronal Na + /K + –adenosine triphosphatase [ATPase]) mutation, D801N): sudden unexpected death in epilepsy (SUDEP) occurs during seizures and is due to terminal apneas in some and due to lethal cardiac arrhythmias in others; and Atp1a3 Mashl/+ mice have central cardiorespiratory dysregulation and abnormal respiratory drive.
Methods
Comparison was made of littermate wild‐type and Atp1a3 Mashl/+ groups using (1) simultaneous in vivo video‐telemetry recordings of electroencephalogram, electrocardiogram, and breathing; (2) whole‐body plethysmography; and (3) hypoglossal nerve recordings.
Results
In Atp1a3 Mashl/+ mice, (1) SUDEP consistently occurred during seizures that were more severe than preterminal seizures; (2) seizure clustering occurred in periods preceding SUDEP; (3) slowing of breathing rate (BR) and heart rate was observed preictally before preterminal and terminal seizures; and (4) the sequence during terminal seizures was as follows: bradypnea with bradycardia/cardiac arrhythmias, then terminal apnea, followed by terminal cardiac arrhythmias. Compared to wild‐type, mutants showed (1) abnormal resting BR variability but no difference in cardiac PR, QRS, QTc, or RR intervals; (2) abnormal hypoglossal nerve firing in response to hypoxia; and (3) abnormal whole‐body plethysmography, consisting of baseline predisposition to apnea and abnormal responses to respiratory challenge. Significance Atp1a3 Mashl/+ , an alternating hemiplegia of childhood (AHC) model, is also a revealing SUDEP model of Na + /K + ‐ATPase mutation resulting in abnormal central respiratory drive and in progressive cardiorespiratory dysregulation concurrent with worsening epilepsy. SUDEP results from seizure‐triggered bradypnea/bradycardia followed by terminal apnea, then terminal cardiac arrhythmias. Because many epilepsy/SUDEP models of other etiologies manifest secondary ATPase deficiency, future studies in those models may benefit from considering possible contributions of ATPase dysfunction to SUDEP in those models too.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Pediatric Neurology and Developmental Medicine, Department of Pediatrics, Duke University, Durham, North Carolina, USA.
- Division of Pediatric Cardiology, Department of Pediatrics, Duke University, Durham, North Carolina, USA.
- Division of Pediatric Pulmonary and Sleep Medicine, Department of Pediatrics, Duke University, Durham, North Carolina, USA.
- Department of Neurobiology, Duke University, Durham, North Carolina, USA.
ORCID-Profile: Arsen S Hunanyan, Andrew P Landstrom, Mohamad A Mikati
Förderung
- NHLBI NIH HHS
- Duke University
- NIGMS NIH HHS
- NIH HHS
- Cure AHC
- National Institutes of Health
Zitieren
APA
Hunanyan, A. S., Verma, A., Bidzimou, M. T., Biswas, D. D., Da Cruz, E., Srour, M. K., Marek, J., Hume, C., Elmallah, M. K., Landstrom, A. P., & Mikati, M. A. (2025). Progressive central cardiorespiratory rate downregulation and intensifying epilepsy lead to sudden unexpected death in epilepsy in mouse model of the most common human ATP1A3 mutation. Epilepsia. https://doi.org/10.1111/epi.18236
Vancouver
Hunanyan AS, Verma A, Bidzimou MT, Biswas DD, Da Cruz E, Srour MK, et al. Progressive central cardiorespiratory rate downregulation and intensifying epilepsy lead to sudden unexpected death in epilepsy in mouse model of the most common human ATP1A3 mutation. Epilepsia. 2025. doi:10.1111/epi.18236
BibTeX
@article{Hunanyan2025,
author = {Hunanyan, Arsen S and Verma, Amitesh and Bidzimou, Minu-Tshyeto and Biswas, Debolina D and Da Cruz, Emily and Srour, Meredith K and Marek, Joshua and Hume, Cordelia and Elmallah, Mai K and Landstrom, Andrew P and Mikati, Mohamad A},
title = {Progressive central cardiorespiratory rate downregulation and intensifying epilepsy lead to sudden unexpected death in epilepsy in mouse model of the most common human ATP1A3 mutation},
journal = {Epilepsia},
year = {2025},
doi = {10.1111/epi.18236}
}
EUVIMED